Halozyme Therapeutics, Inc.
US ˙ NasdaqGS ˙ US40637H1095

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari LaBarre Michael J.. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa LaBarre Michael J. telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:HALO / Halozyme Therapeutics, Inc. SVP, CHIEF TECHNICAL OFFICER 173,756
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh LaBarre Michael J.. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam HALO / Halozyme Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di HALO / Halozyme Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam HALO / Halozyme Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di HALO / Halozyme Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2023-02-16 HALO LaBarre Michael J. 2,878 49.2600 2,878 49.2600 141,770 81 30.2800 -54,624 -38.53

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

HALO / Halozyme Therapeutics, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh LaBarre Michael J. sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 173,756 -0.06 58.74 -5,874 10,206,427
2025-02-27 2025-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,597 173,856 -0.91 58.25 -93,028 10,127,460
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 175,453 -0.34 58.65 -35,189 10,289,968
2025-02-27 2025-02-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,400 176,053 -5.07 58.09 -546,055 10,227,095
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -700 185,453 -0.38 58.67 -41,069 10,880,528
2025-02-27 2025-02-25 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,300 186,153 -4.76 58.01 -539,465 10,798,177
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,410 195,453 -1.22 57.75 -139,178 11,287,411
2025-02-24 2025-02-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,747 197,863 2.46
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,164 193,116 -1.11 58.29 -126,140 11,256,732
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,263 195,280 2.23
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,103 191,017 -1.60 58.29 -180,874 11,134,381
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 194,120 3.25
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -8,721 188,008 -4.43 58.29 -508,347 10,958,986
2025-02-18 2025-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 20,891 196,729 11.88
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,304 175,838 -0.74 58.29 -76,010 10,249,597
2025-02-18 2025-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 177,142 1.95
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 173,756 -5.44 53.26 -532,590 9,254,071
2024-10-16 2024-10-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 19.98 199,800 3,671,445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -77 173,756 -0.04 54.24 -4,177 9,425,394
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,923 173,833 -5.40 53.74 -533,292 9,342,307
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 4,491 183,756 2.51 19.98 89,730 3,671,445
2024-10-16 2024-10-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 5,509 179,265 3.17 16.65 91,725 2,984,762
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,037 173,756 -1.16 62.58 -127,477 10,873,824
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,963 175,793 -4.33 61.89 -492,838 10,880,005
2024-09-18 2024-09-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 16.65 166,500 3,059,537
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 173,756 -5.44 62.88 -628,780 10,925,430
2024-09-18 2024-09-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 183,756 5.76 16.65 166,500 3,059,537
2024-08-27 2024-08-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,580 173,756 3.32 18.41 102,728 3,198,848
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -100 168,176 -0.06 62.34 -6,234 10,484,092
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,900 168,276 -5.56 61.74 -611,236 10,389,529
2024-08-21 2024-08-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 16.65 166,500 2,966,630
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 61.06 -610,550 10,267,986
2024-08-21 2024-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 16.65 166,500 2,966,630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 55.12 -551,150 9,269,020
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,285 178,176 4.88 16.65 137,945 2,966,630
2024-07-24 2024-07-24 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,715 169,891 1.02 8.11 13,909 1,377,816
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5,291 168,176 -3.05 55.26 -292,407 9,294,247
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,709 173,467 -2.64 54.46 -256,466 9,447,533
2024-07-24 2024-07-23 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 49.43 -494,260 8,312,267
2024-06-20 2024-06-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 45.38 -453,840 7,632,500
2024-05-22 2024-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 45.16 -451,640 7,595,501
2024-05-22 2024-05-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 38.49 -384,890 6,472,926
2024-04-17 2024-04-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 168,176 -5.61 38.35 -383,500 6,449,550
2024-04-17 2024-04-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 178,176 5.95 8.11 81,100 1,445,007
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2,890 168,176 1.75 8.11 23,438 1,363,907
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 292 165,286 0.18 16.78 4,900 2,773,499
2024-03-26 2024-03-26 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,436 164,994 5.39 12.07 101,823 1,991,478
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 156,558 -6.00 42.27 -422,730 6,618,176
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 3,551 166,558 2.18 8.11 28,799 1,350,785
2024-03-13 2024-03-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 6,449 163,007 4.12 12.07 77,839 1,967,494
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 156,558 -6.00 41.64 -416,370 6,518,605
2024-03-13 2024-03-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 166,558 6.39 12.07 120,700 2,010,355
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,471 156,558 -4.55 39.54 -295,418 6,190,616
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 7,471 164,029 4.77 8.11 60,590 1,330,275
2024-02-28 2024-02-28 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,529 156,558 -1.59 39.56 -100,045 6,193,278
2024-02-28 2024-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 159,087 -5.91 39.95 -399,460 6,354,889
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,160 169,087 -1.26 36.10 -77,976 6,104,041
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 4,264 171,247 2.55
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,097 166,983 -1.82 36.10 -111,802 6,028,086
2024-02-20 2024-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 170,080 3.73
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,832 163,968 -2.28 35.91 -137,607 5,888,091
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
A - Award 8,479 167,800 5.32
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,208 159,321 -0.75 35.91 -43,379 5,721,217
2024-02-16 2024-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 160,529 2.15
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,901 157,143 -1.81 35.49 -102,956 5,577,005
2024-02-13 2024-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 160,044 5.35
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.00 -360,000 5,468,796
2024-01-18 2024-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.00 -360,000 5,468,796
2024-01-18 2024-01-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 40.39 -403,940 6,136,293
2023-12-13 2023-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 12.07 120,700 1,954,266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -643 151,911 -0.42 40.46 -26,019 6,147,079
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,357 152,554 -5.78 39.58 -370,303 6,037,325
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,467 161,911 0.91 12.07 17,707 1,954,266
2023-12-13 2023-12-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,533 160,444 5.62 13.81 117,841 2,215,732
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 39.79 -397,880 6,044,235
2023-11-16 2023-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 13.81 138,100 2,235,991
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,708 151,911 -1.11 39.08 -66,747 5,936,530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,708 153,619 1.12 16.78 28,660 2,577,727
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,292 151,911 -5.18 39.08 -324,043 5,936,530
2023-11-16 2023-11-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,292 160,203 5.46 13.81 114,513 2,212,403
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 36.52 -365,200 5,547,790
2023-10-17 2023-10-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 19.98 199,800 3,234,982
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 151,911 -6.18 39.10 -390,980 5,939,416
2023-09-19 2023-09-19 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 161,911 6.58 19.98 199,800 3,234,982
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,075 151,911 -5.05 42.41 -342,437 6,442,090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 8,075 159,986 5.32 19.98 161,338 3,196,520
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,925 151,911 -1.25 42.41 -81,633 6,442,090
2023-08-23 2023-08-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 1,925 153,836 1.27 18.41 35,439 2,832,121
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 2,825 151,911 1.89 8.11 22,911 1,231,998
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,175 149,086 5.06 13.81 99,087 2,058,878
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 40.43 -404,300 5,737,462
2023-07-19 2023-07-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 36.00 -360,000 5,108,796
2023-06-22 2023-06-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,984 141,911 -2.06 49.55 -147,854 7,031,548
2023-04-19 2023-02-27 4/A HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 2,984 144,895 2.10 18.41 54,935 2,667,517
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 141,911 -6.58 36.00 -360,000 5,108,796
2023-04-19 2023-04-18 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 10,000 151,911 7.05 18.41 184,100 2,796,682
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -2,984 138,927 -2.10 49.55 -147,854 6,883,694
2023-02-28 2023-02-27 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,016 141,911 -4.71 49.55 -347,629 7,031,406
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale -2,878 148,927 -1.90 49.26 -141,770 7,336,144
2023-02-21 2023-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 6,112 151,805 4.20
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,170 145,693 -0.80 49.20 -57,564 7,168,096
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 146,863 2.36
2023-02-17 2023-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -10,000 143,477 -6.52 48.39 -483,940 6,943,426
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 153,477 -1.74 48.92 -133,307 7,508,095
2023-02-14 2023-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 156,202 5.31
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,951 148,319 -1.95 48.92 -144,363 7,255,765
2023-02-14 2023-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 151,270 5.68
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -1,122 143,137 -0.78 50.93 -57,139 7,289,395
2023-01-18 2023-01-17 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8,878 144,259 -5.80 50.40 -447,451 7,270,654
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -5,065 153,137 -3.20 58.66 -297,133 8,983,629
2022-12-13 2022-12-13 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,935 158,202 -3.03 58.67 -289,541 9,281,870
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -3,115 163,137 -1.87 54.14 -168,643 8,832,074
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -8 166,252 0.00 54.61 -437 9,079,022
2022-11-16 2022-11-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6,877 166,260 -3.97 54.12 -372,183 8,997,991
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 24,448 24,448
2022-02-17 2022-02-16 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 74,777 74,777
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -3,386 10,158 -25.00
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,170 173,137 -0.67 34.43 -40,283 5,961,107
2022-02-17 2022-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 3,386 174,307 1.98
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,771 0 -100.00
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,995 170,921 -1.15 33.64 -67,112 5,749,782
2022-02-14 2022-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,771 172,916 3.45
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 7,883 -50.00
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 167,145 -1.60 34.20 -93,195 5,716,359
2022-02-14 2022-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 169,870 4.87
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,133 16,266 -33.33
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,992 161,987 -1.81 34.94 -104,540 5,659,826
2022-02-14 2022-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,133 164,979 5.19
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -8,050 0 -100.00
2021-10-12 2021-10-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,050 156,846 5.41 13.10 105,455 2,054,683
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -29,450 8,050 -78.53
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -29,450 148,796 -16.52 39.93 -1,175,968 5,941,573
2021-10-01 2021-10-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise X 29,450 178,246 19.79 13.10 385,795 2,335,023
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -14,685 0 -100.00
2021-07-15 2021-07-15 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 14,685 148,796 10.95 6.55 96,187 974,614
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -40,315 14,685 -73.30
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -40,315 134,111 -23.11 45.70 -1,842,315 6,128,604
2021-07-06 2021-07-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 40,315 174,426 30.06 6.55 264,063 1,142,490
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -11,311 0 -100.00
2021-05-03 2021-05-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,311 134,111 9.21 11.29 127,701 1,514,113
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -28,689 11,311 -71.72
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -18,994 122,800 -13.40 42.79 -812,829 5,255,103
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -9,695 141,794 -6.40 42.10 -408,208 5,970,236
2021-04-01 2021-04-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 28,689 151,489 23.36 11.29 323,899 1,710,311
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -6,530 122,800 -5.05 46.26 -302,061 5,680,409
2021-03-01 2021-03-01 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11,794 129,330 -8.36 45.56 -537,303 5,891,926
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,803 0 -100.00
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4,364 141,124 -3.00 48.69 -212,483 6,871,328
2021-02-22 2021-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,803 145,488 6.44
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 13,544 13,544
2021-02-17 2021-02-15 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 23,311 23,311
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,771 5,771 -50.00
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,272 136,685 -1.64 49.84 -113,236 6,812,380
2021-02-16 2021-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,771 138,957 4.33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 15,766 -33.33
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 133,186 -2.00 49.84 -135,814 6,637,990
2021-02-12 2021-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 135,911 6.16
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,134 24,399 -25.00
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,906 128,028 -2.22 50.60 -147,044 6,478,217
2021-02-12 2021-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,134 130,934 6.62
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -600 122,800 -0.49 43.25 -25,951 5,311,346
2020-12-21 2020-12-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -11,400 123,400 -8.46 42.54 -484,967 5,249,559
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -7,889 134,800 -5.53 39.04 -307,955 5,262,053
2020-11-20 2020-11-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -4,111 142,689 -2.80 38.24 -157,221 5,456,998
2020-10-20 2020-10-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 146,800 -7.56 30.43 -365,148 4,466,977
2020-09-21 2020-09-21 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 158,800 -7.03 26.91 -322,884 4,272,832
2020-08-20 2020-08-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 170,800 -6.56 28.30 -339,564 4,833,128
2020-07-20 2020-07-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -12,000 182,800 -6.16 29.01 -348,072 5,302,297
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -18,613 0 -100.00
2020-05-22 2020-05-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 18,613 194,800 10.56 7.14 132,897 1,390,872
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
M - Exercise -21,387 18,613 -53.47
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
S - Sale X -21,387 176,187 -10.82 23.80 -509,075 4,193,779
2020-05-21 2020-05-20 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 21,387 197,574 12.14 7.14 152,703 1,410,678
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -8,803 8,803 -50.00
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -3,044 176,187 -1.70 21.83 -66,451 3,846,162
2020-02-24 2020-02-22 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 8,803 179,231 5.17
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -5,772 11,542 -33.34
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -1,995 170,428 -1.16 21.10 -42,094 3,596,031
2020-02-18 2020-02-14 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 5,772 172,423 3.46
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
M - Exercise -7,883 23,649 -25.00
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -2,725 166,651 -1.61 20.00 -54,500 3,333,020
2020-02-13 2020-02-12 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 7,883 169,376 4.88
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Restricted Stock Units
A - Award 32,533 32,533
2020-02-12 2020-02-10 4 HALO HALOZYME THERAPEUTICS, INC.
Option to Purchase Common Stock
A - Award 69,174 69,174
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,559 0 -100.00
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
F - Taxes -4,289 161,493 -2.59 19.21 -82,392 3,102,281
2020-02-04 2020-02-03 4 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
M - Exercise 11,559 165,782 7.49
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
2020-01-06 3 HALO HALOZYME THERAPEUTICS, INC.
Common Stock
308,446
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)